投稿信息
投稿信息
審稿周期
投稿命中率
審稿費用
暫無數據
版面費用
暫無數據
中國人發(fā)表比例
2023年中國人文章占該期刊總數量暫無數據 (2022年為100.00%)
自引率
9.6 %
年文章數
3008
NCBI查詢
偏重的研究方向
期刊簡介
稿件收錄要求
稿件收錄要求
Well-established as a major journal in today's rapidly advancing experimental and clinical research, Endocrine should be your first choice for the rapid publication of full length articles devoted to the molecular, cellular, biochemical, and physiological aspects of endocrinology, including both clinical papers relating to significant endocrine phenomena that are appropriately controlled and methodological papers of special interest to workers in this area.
